Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection

被引:0
|
作者
Margo Shoup
Mitbat Gonen
Michael D’Angelica
William R. Farnagin
Ronald P. DeMatteo
Lawrence H. Schwartz
Scott Tuorto
Leslie H. Blumgart
Yuman Fong
机构
[1] Memorial Sloan-Kettering Cancer Center,Department of Surgery
[2] Memorial Sloan-Kettering Cancer Center,Departments of Biostatistics
[3] Memorial Sloan-Kettering Cancer Center,Departments of Radiology
来源
Journal of Gastrointestinal Surgery | 2003年 / 7卷
关键词
Hepatic dysfunction; liver resection; metastasis;
D O I
暂无
中图分类号
学科分类号
摘要
Liver-enhancing modalities, such as portal vein embolization, are increasingly employed prior to major liver resection to prevent postoperative liver dysfunction. Selection criteria for such techniques are not well described. This study uses CT-based volumetric analysis as a tool to identify patients at highest risk for postoperative hepatic dysfunction. Between July 1999 and December 2000, a total of 126 consecutive patients who were undergoing liver resection for colorectal metastasis and had CT scans at our institution were included in the analysis. Volume of resection was determined by semiautomated contouring of the liver on preoperative volumetrically (helical) acquired CT scans. Hepatic dysfunction was defined as prothrombin time greater than 18 seconds or serum bilirubin level greater than 3 mg/dl. Marginal regression was used to compare the predictive ability of volumetric analysis and the extent of resection. The percentage of liver remaining was closely correlated with increasing prothrombin time and bilirubin level (P < 0.001). After trisegmentectomy, 90% of patients with ≤s25% of liver remaining developed hepatic dysfunction, compared with none of the patients with more than 25% of liver remaining after trisegmentectomy (P < 0.0001). The percentage of liver remaining was more specific in predicting hepatic dysfunction than was the anatomic extent of resection (P = 0.003). Male sex nearly doubled the risk of hepatic dysfunction (odds ratio = 1.89, P = 0.027), and having ≤25% of liver remaining more than tripled the risk (odds ratio = 3.09, P < 0.0001). Hepatic dysfunction and ≤25% of liver remaining were associated with increased complications and length of hospital stay (P < 0.0001 and P = 0.0003, respectively). Preoperative assessment of future liver volume remaining distinguishes which patients undergoing liver resection will most likely benefit from preoperative liver enhancement techniques such as portal vein embolization.
引用
收藏
页码:325 / 330
页数:5
相关论文
共 50 条
  • [41] Analysis of risk factors for postoperative liver insufficiency in patients undergoing liver resection
    Hou, Hong-Wei
    Wang, Dong
    Wang, Jin-Min
    Wu, Rong
    Pan, Zheng
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 164 - 164
  • [42] The Role of the Multiparametric MRI LiverMultiScan™ in the Quantitative Assessment of the Liver and Its Predicted Clinical Applications in Patients Undergoing Major Hepatic Resection for Colorectal Liver Metastasis
    Chouari, Tarak
    Merali, Nabeel
    La Costa, Francesca
    Santol, Jonas
    Chapman, Shelley
    Horton, Alex
    Aroori, Somaiah
    Connell, John
    Rockall, Timothy A.
    Mole, Damian
    Starlinger, Patrick
    Welsh, Fenella
    Rees, Myrddin
    Frampton, Adam E.
    CANCERS, 2023, 15 (19)
  • [43] Digital determination and predictors of hepatic steatosis in patients undergoing resection for colorectal liver metastases
    Parkin, E.
    Rao, M.
    Sherlock, D. J.
    Renehan, A. G.
    O'Reilly, D. A.
    BRITISH JOURNAL OF SURGERY, 2013, 100 : 126 - 127
  • [44] Digital histology quantification of intra-hepatic fat in patients undergoing liver resection
    Parkin, E.
    O'Reilly, D. A.
    Plumb, A. A.
    Manoharan, P.
    Rao, M.
    Coe, P.
    Frystyk, J.
    Ammori, B.
    Carino, N. de Liguori
    Deshpande, R.
    Sherlock, D. J.
    Renehan, A. G.
    EJSO, 2015, 41 (08): : 1020 - 1027
  • [45] Results of Preoperative Hepatic Arterial Infusion Chemotherapy in Patients Undergoing Liver Resection for Colorectal Liver Metastases
    Carlo Pulitanò
    Marcella Arru
    Marco Catena
    Eleonora Guzzetti
    Giordano Vitali
    Monica Ronzoni
    Massimo Venturini
    Eugenio Villa
    Gianfranco Ferla
    Luca Aldrighetti
    Annals of Surgical Oncology, 2008, 15 : 1661 - 1669
  • [46] Results of preoperative hepatic arterial infusion chemotherapy in patients undergoing liver resection for colorectal liver metastases
    Pulitano, Carlo
    Arru, Marcella
    Catena, Marco
    Guzzetti, Eleonora
    Vitali, Giordano
    Ronzoni, Monica
    Venturini, Massimo
    Villa, Eugenio
    Ferla, Gianfranco
    Aldrighetti, Luca
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (06) : 1661 - 1669
  • [47] Outcomes in elderly patients undergoing hepatic resection compared to liver transplant for hepatocellular carcinoma
    Khan, Sameer A.
    Ahmed, Fasih A.
    Hafeez, Muhammad S.
    Feng, Lawrence R.
    Seth, Abhinav
    Kwon, Yong K.
    Aziz, Hassan
    JOURNAL OF SURGICAL ONCOLOGY, 2023, 128 (08) : 1320 - 1328
  • [48] The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis
    Wang, Kun
    Xu, Da
    Yan, Xiao-Luan
    Poston, Graeme
    Xing, Bao-Cai
    EJSO, 2018, 44 (06): : 771 - 777
  • [49] The value of indocyanine green clearance assessment to predict postoperative liver dysfunction in patients undergoing liver resection
    Christoph Schwarz
    Immanuel Plass
    Fabian Fitschek
    Antonia Punzengruber
    Martina Mittlböck
    Stephanie Kampf
    Ulrika Asenbaum
    Patrick Starlinger
    Stefan Stremitzer
    Martin Bodingbauer
    Klaus Kaczirek
    Scientific Reports, 9
  • [50] Major hepatic resection for hilar cholangiocarcinoma: Analysis of 46 patients - Discussion
    Brems, JJ
    Moore, EE
    Nagorney, DM
    Remine, SG
    Talamonti, M
    Liu, KJM
    ARCHIVES OF SURGERY, 2004, 139 (05) : 523 - 525